PANGRAF 0.5MG CAP

About

Tacrolimus is a potent immunosuppressant belonging to the calcineurin inhibitor class, primarily utilized to prevent organ rejection in patients who have undergone allogeneic transplantation of organs such as the liver, kidney, or heart. Its mechanism of action involves inhibiting T-lymphocyte activation, a critical step in the immune response that leads to graft rejection. Tacrolimus achieves this by binding to an intracellular protein, FKBP-12, forming a complex that then inhibits calcineurin, a phosphatase essential for the transcription of genes encoding various cytokines vital for T-cell proliferation and differentiation. This targeted suppression of the immune system helps the body accept the new organ. Given its narrow therapeutic index and the potential for significant adverse effects, tacrolimus therapy necessitates meticulous monitoring of blood concentrations to ensure optimal immunosuppression while mitigating toxicity. It is frequently administered as part of a multi-drug immunosuppressive regimen to achieve synergistic effects and reduce individual drug dosages.

Uses

• Prevention of organ rejection in kidney transplant patients.
• Prevention of organ rejection in liver transplant patients.
• Prevention of organ rejection in heart transplant patients.
• Treatment of moderate to severe atopic dermatitis (topical formulations).

Directions For Use

Take orally as directed by your physician, usually twice daily, on an empty stomach for consistent absorption. Do not crush or chew the capsules.

Benefits

• Highly effective in preventing organ transplant rejection.
• Reduces the risk of acute and chronic rejection episodes.
• Allows for successful long-term organ graft survival.
• Available in various formulations for tailored therapy.
• Can be part of a multi-drug immunosuppressive regimen.
• Improves quality of life for transplant recipients.

Side Effects

• Nephrotoxicity (kidney damage)
• Neurotoxicity (tremor, headache, seizures)
• Hyperglycemia (elevated blood sugar)
• Hypertension (high blood pressure)
• Hyperkalemia (high potassium levels)
• Gastrointestinal disturbances (nausea, diarrhea)
• Infections (due to immunosuppression)
• Malignancies (lymphoma, skin cancer)
• Anemia
• Insomnia
• Alopecia
• Peripheral edema

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may increase the risk of liver toxicity and other side effects, and can interact with the medication.
• Pregnancy - Tacrolimus should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus, as it can cross the placenta. Close monitoring is essential.
• Breastfeeding - Tacrolimus is excreted in breast milk and may cause serious adverse reactions in a nursing infant. Breastfeeding is generally not recommended.
• Liver - Use with caution in patients with liver impairment; dose adjustments may be necessary due to altered metabolism and increased risk of toxicity.
• Kidney - Tacrolimus is nephrotoxic; close monitoring of kidney function is crucial, and dose adjustments may be required, especially in pre-existing renal dysfunction.
• Lung - While not a primary concern, tacrolimus can rarely cause interstitial lung disease. Monitor for new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.